The effects of levosimendan on haemodynamics in patients undergoing elective aortic valve replacement (AVR) together with coronary artery bypass grafting (CABG) surgry
- Conditions
- Aortic valve dysfunction and coronary artery diseaseMedDRA version: 9.1Level: LLTClassification code 10011078Term: Coronary artery diseaseMedDRA version: 9.1Level: LLTClassification code 10002916Term: Aortic valve replacement
- Registration Number
- EUCTR2008-001672-70-FI
- Lead Sponsor
- Heli Leppikangas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method